Nanomedicine and Neurosciences : Advantages, limitations and safety aspects /

Saved in:
Bibliographic Details
Imprint:Sharjah : Bentham Science Publishers, 2017.
Description:1 online resource (285 pages)
Language:English
Series:Frontiers in Nanomedicine ; v. 2
Frontiers in Nanomedicine ; v. 2.
Subject:Medical technology.
Nanotechnology.
Medical innovations.
HEALTH & FITNESS -- Holism.
HEALTH & FITNESS -- Reference.
MEDICAL -- Alternative Medicine.
MEDICAL -- Atlases.
MEDICAL -- Essays.
MEDICAL -- Family & General Practice.
MEDICAL -- Holistic Medicine.
MEDICAL -- Osteopathy.
Medical innovations.
Medical technology.
Nanotechnology.
Electronic books.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11758938
Hidden Bibliographic Details
Other authors / contributors:Tosi, Giovanni.
ISBN:1681084937
9781681084930
Notes:Neuronopathic LSDs: Quest for Treatments Drives Research in Nanomedicine and Nanotechnology.
Includes bibliographical references and index.
Print version record.
Other form:Print version: Tosi, Giovanni. Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects. Sharjah : Bentham Science Publishers, ©2017 9781681084947
LEADER 05956cam a2200745 i 4500
001 11758938
005 20210426223535.8
006 m o d
007 cr |n|---|||||
008 170819s2017 ts ob 001 0 eng d
003 ICU
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d MERUC  |d YDX  |d OCLCQ  |d N$T  |d G3B  |d IGB  |d STF  |d OCLCF  |d OCLCQ  |d UKAHL  |d OCLCQ 
019 |a 1001260936 
020 |a 1681084937 
020 |a 9781681084930  |q (electronic bk.) 
035 |a (OCoLC)1001374578  |z (OCoLC)1001260936 
050 4 |a R855.3 
072 7 |a HEA  |x 012000  |2 bisacsh 
072 7 |a HEA  |x 020000  |2 bisacsh 
072 7 |a MED  |x 004000  |2 bisacsh 
072 7 |a MED  |x 101000  |2 bisacsh 
072 7 |a MED  |x 109000  |2 bisacsh 
072 7 |a MED  |x 029000  |2 bisacsh 
072 7 |a MED  |x 040000  |2 bisacsh 
072 7 |a MED  |x 092000  |2 bisacsh 
049 |a MAIN 
245 0 0 |a Nanomedicine and Neurosciences :  |b Advantages, limitations and safety aspects /  |c editor, Giovanni Toasi. 
260 |a Sharjah :  |b Bentham Science Publishers,  |c 2017. 
300 |a 1 online resource (285 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers in Nanomedicine ;  |v v. 2 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a FOREWORD ; PREFACE ; List of Contributors ; Nanomedicine and Neurodegenerative Diseases: An Introduction to Pathology and Drug Targets ; Tasnuva Sarowar1 and Andreas M. Grabrucker2,*; INTRODUCTION; CLINICAL REPRESENTATIONS; Alzheimer's Disease; Core Features of AD; Symptoms & Diagnosis of AD; Parkinson's Disease; Symptoms & Core Features of PD; Diagnosis of PD; Amytropohic Lateral Sclerosis; Core Features of ALS; Symptoms & Diagnosis of ALS; ANATOMY AND PATHOLOGY; Initiation and Progression; Alzheimer's Disease; Parkinson's Disease; Other Neurodegenerative Disorders. 
505 8 |a Brain Morphology, Cellular Pathology and Neurobiology of the DiseaseAlzheimer's Disease; Parkinson's Disease; Amyloid Lateral Sclerosis; GENES AND ENVIRONMENT; ; Genetics of Neurodegenerative Diseases; Candidate Genes for Alzheimer's Disease; Parkinson's Disease; Candidate Genes for Parkinson's Disease; Candidate Genes for ALS; Environmental Risk Factors; Trace Metal Alterations; Other Risk Factors; ANIMAL MODELS; Animal Models for AD; Animal Models for PD; Animal Models for ALS; Animal Models for HD; DRUG TARGETS IN NEURODEGENERATIVE DISORDERS; Drug Targets in AD; Drug Targets in PD. 
505 8 |a TREATMENT OF NEURODEGENERATIVE DISORDERS USING NANOMEDICINECONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGEMENT; REFERENCES; Nanoparticles Targeting Mitochondria in Neurodegenerative Diseases: Toxicity and Challenge for Nanotherapeutics ; Michal Cagalinec*; INTRODUCTION AND OVERVIEW; ALZHEIMER'S AND PARKINSON'S DISEASE; MITOCHONDRIA; MITOCHONDRIAL FUSION AND FISSION; NANOPARTICLES AND THE BRAIN; NANOPARTICLES' TOXICITY, FOCUS ON NEUROTOXICITY; NANOPARTICLES AS DRUG CARRIERS; MITOCHONDRIA AND ALZHEIMER'S DISEASE; MITOCHONDRIA AND PARKINSON'S DISEASE. 
505 8 |a NANOPARTICLES AND ALZHEIMER'S DISEASE TREATMENTNANOPARTICLES AND PARKINSON'S DISEASE TREATMENT; NANOPARTICLES AS DRUG DELIVERY SYSTEMS TO MITO- CHONDRIA; COULD NANOPARTICLES IMPROVE MITOCHONDRIAL FUNCTION- ING WITHOUT ENTERING MITOCHONDRIA?; FUTURE DIRECTIONS, PERSPECTIVES, LIMITATIONS; CONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; ABBREVIATIONS; REFERENCES; Neuronal Mechanisms for Nanotopography Sensing ; Ilaria Tonazzini1,2 and Marco Cecchini1,*; INTRODUCTION; Focal Adhesions and Cytoskeleton during Neuronal Cell-nanograting Interaction. 
505 8 |a Neuronal Differentiation Drives Nanotopography SensingNoise Tolerance in Neuronal Contact Guidance; CONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; Drug Delivery to the Brain by Liposomal Carrier Systems ; Anne Mahringer and Gert Fricker*; INTRODUCTION; LIPOSOMES; TRANSFERRIN RECEPTOR; INSULIN RECEPTOR; LDL RECEPTOR; LEPTIN RECEPTOR; RECEPTOR OF ADVANCED GLYCATION END PRODUCTS; ABSORPTIVE-MEDIATED TRANSCYTOSIS ACROSS THE BBB; ULTRASOUND AND LIPOSOMES TO OVERCOME THE BBB; CONCLUSION; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES. 
500 |a Neuronopathic LSDs: Quest for Treatments Drives Research in Nanomedicine and Nanotechnology. 
650 0 |a Medical technology.  |0 http://id.loc.gov/authorities/subjects/sh85083046 
650 0 |a Nanotechnology.  |0 http://id.loc.gov/authorities/subjects/sh91001490 
650 0 |a Medical innovations.  |0 http://id.loc.gov/authorities/subjects/sh85082946 
650 7 |a HEALTH & FITNESS  |x Holism.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Reference.  |2 bisacsh 
650 7 |a MEDICAL  |x Alternative Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Atlases.  |2 bisacsh 
650 7 |a MEDICAL  |x Essays.  |2 bisacsh 
650 7 |a MEDICAL  |x Family & General Practice.  |2 bisacsh 
650 7 |a MEDICAL  |x Holistic Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Osteopathy.  |2 bisacsh 
650 7 |a Medical innovations.  |2 fast  |0 (OCoLC)fst01014181 
650 7 |a Medical technology.  |2 fast  |0 (OCoLC)fst01014742 
650 7 |a Nanotechnology.  |2 fast  |0 (OCoLC)fst01032639 
655 4 |a Electronic books. 
700 1 |a Tosi, Giovanni. 
776 0 8 |i Print version:  |a Tosi, Giovanni.  |t Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects.  |d Sharjah : Bentham Science Publishers, ©2017  |z 9781681084947 
830 0 |a Frontiers in Nanomedicine ;  |v v. 2. 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1580981  |y eBooks on EBSCOhost 
903 |a HeVa 
903 |a HeVa 
929 |a oclccm 
999 f f |i f20b726c-1145-5169-b79b-4c3d03b35916  |s c5a14989-16b3-5272-a741-bbb9cb28ee32 
928 |t Library of Congress classification  |a R855.3  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1580981  |z eBooks on EBSCOhost  |g ebooks  |i 12455935